JORGE BENITO
CANNATA ANDIA
Investigador hasta 2022
Hospital Universitario Doctor Peset
Valencia, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario Doctor Peset (10)
2023
2022
-
Recommendations of the Spanish Society of Nephrology for the management of mineral and bone metabolism disorders in patients with chronic kidney disease: 2021 (SEN-MM)
Nefrologia, Vol. 42, pp. 1-37
-
Safety and effectiveness of sucroferric oxyhydroxide in Spanish patients on dialysis: sub-analysis of the VERIFIE study
Nefrologia, Vol. 42, Núm. 5, pp. 594-606
2018
2015
-
Improvement of mineral and bone metabolism markers is associated with better survival in haemodialysis patients: The COSMOS study
Nephrology Dialysis Transplantation, Vol. 30, Núm. 9, pp. 1542-1551
2013
-
COSMOS: The dialysis scenario of CKD-MBD in Europe
Nephrology Dialysis Transplantation, Vol. 28, Núm. 7, pp. 1922-1935
-
Influence of body mass index on the association of weight changes with mortality in hemodialysis patients
Clinical Journal of the American Society of Nephrology, Vol. 8, Núm. 10, pp. 1725-1733
-
Use of phosphate-binding agents is associated with a lower risk of mortality
Kidney International, Vol. 84, Núm. 5, pp. 998-1008
2008
-
Current Management of Secondary Hyperparathyroidism: A Multicenter Observational Study (COSMOS)
Journal of Nephrology, Vol. 21, Núm. 3, pp. 290-298